Lupus & antiphospholipid syndrome
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis
Authors' conclusion
In this meta-analysis, we found a weighted pooled prevalence of biopsy-verified CD in patients with SLE comparable with the prevalence in the general population.
Study context
- Population
- Patients with SLE; Medline, Embase, Cochrane and Web of Science Core Collection, 1 January 1990 to 9 July 202314 studies
- Outcome
- Pooled prevalence of biopsy-verified coeliac disease (CD)
Methodological detailsmeta-regression, Joanna Briggs Institute Critical Appraisal Tool
- Meta-regression
- Joanna Briggs Institute Critical Appraisal Tool
Pooled result
As reported in the abstract
Biopsy-verified CD, weighted pooled prevalence
SLE
0.7%
14 events
Further pooled results
| Outcome | Values |
|---|---|
| CD serological markers, weighted pooled prevalence | SLE 3.7% (95% CI 1.4–6.7) |
- Coeliac disease (CD) serological markers, weighted pooled prevalence: 1063 patients with SLE
Meta-regression of CD prevalence
- No associations between CD prevalence and study characteristics, demographics and quality assessment scores
Original publication
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus Sci Med. Published 13 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →